NASDAQ: GNPXGenprex Inc Stock Ownership - Who owns Genprex?
Insider buying vs selling
Have Genprex Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark Stanley Berger | Chief Medical Officer | 2025-06-30 | 4,500 | $0.23 | $1.03kSell |
| Ryan M. Confer | President CEO and CFO | 2025-06-30 | 5,775 | $0.23 | $1.32kSell |
| Mark Stanley Berger | Chief Medical Officer | 2025-02-18 | 585 | $0.41 | $239.85Sell |
| Ryan M. Confer | President CEO and CFO | 2025-02-18 | 395 | $0.41 | $161.95Sell |
GNPX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GNPX insiders and whales buy or sell their stock.
GNPX Shareholders
What type of owners hold Genprex Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christy M. Nance | 132.42% | 3,006,298 | $5.29M | Insider |
| Jack A. Roth | 64.39% | 1,461,813 | $2.57M | Insider |
| Vanguard Group Inc | 19.09% | 433,369 | $762.73k | Institution |
| Susquehanna International Group LLP | 14.98% | 340,056 | $598.50k | Institution |
| Catherine M. Vaczy | 11.67% | 265,000 | $466.40k | Insider |
| Jane Street Group LLC | 9.04% | 205,180 | $361.12k | Institution |
| Hermant Kumar | 8.81% | 200,000 | $352.00k | Insider |
| Geode Capital Management LLC | 7.22% | 164,027 | $288.69k | Institution |
| Ubs Group Ag | 7.14% | 162,202 | $285.48k | Institution |
| Ryan M. Confer | 2.01% | 45,661 | $80.36k | Insider |
GNPX vs Biotech Stocks
Genprex Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.